NLNing Luo

Ning Luo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ning Luo has a total of 37 co-authors. Here are the top co-authors by number of shared publications:

  • Xueqing Yu

    Department of Nephrology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China

    2 shared publications
  • Anni Zhong

    School of Biomedical Engineering, Southern Medical University, Guangzhou, China

    1 shared publication
  • Bin Li

    State Key Laboratory of Oncology in South China Guangdong Provincial Clinical Research Center for Cancer Sun Yat‐sen University Cancer Center Guangzhou P. R. China

    1 shared publication
  • Cheng Cheng

    Department of Radiology, Institute of Surgery Research, Daping Hospital, Third Military Medical University, Chongqing 400042, China

    1 shared publication
  • Chengting Jiang

    Of Pharmacy, University of Benin, Benin City, 300001 Nigeria

    1 shared publication
  • Chunna Chen

    Department of Dermatology, Maoming People’s Hospital, Maoming, China

    1 shared publication

Latest Publications

  • Euler common spatial patterns for EEG classification

    by Jing Sun, Mengting Wei, Ning Luo, Zhanli Li, Haixian Wang

    The technique of common spatial patterns (CSP) is a widely used method in the field of feature extraction of electroencephalogram (EEG) signals. Motivated by the fact that a cosine distance can enlarge the distance between samples of different classes, we propose the Euler CSP (e-CSP) for the feature extraction of EEG signals, and it is then used for EEG classification. The e-CSP is essentially the conventional CSP with the Euler representation. It includes the following two stages: each sample value is first mapped into a complex space by using the Euler representation, and then the conventional CSP is performed in the Euler space. Thus, the e-CSP is equivalent to applying the Euler representation as a kernel function to the input of the CSP. It is computationally as straightforward as the CSP. However, it extracts more discriminative features from the EEG signals. Extensive experimental results illustrate the discrimination ability of the e-CSP. Graphical abstract


  • Open Access

    Combined effects of tenofovir and interferon α1b on viral load and levels of peripheral regulatory T cells in chronic hepatitis B subjects

    by Wanfeng Wu, Chengting Jiang, Cheng Cheng, Yihang Sun, Ning Luo, Jinwen Ge

    Purpose: To study the combined effects of tenofovir and interferon α1b on viral load and peripheral blood regulatory T cell concentrations of chronic hepatitis B (CHB) subjects. Methods: Patients with chronic hepatitis B (86 cases) were randomly assigned to two groups: control group and study group. In control subjects, tenofovir was given orally (300 mg/kg bwt/day). In addition to tenofovir, the study group received interferon α1b injection intramuscularly at a dose of 50 μg/kg thrice a week. Liver function, serum hepatitis B viral (HBV) load, and serum levels of peripheral blood regulatory T-lymphocytes were determined. Clinical effectiveness and adverse reactions in both groups were also assessed. Results: After treatment, total effectiveness was higher in the study group (86.04 %) than in control patients (62.79 %) (p < 0.05). Serum aspartate transaminase (AST), alanine aminotransferase (ALT) and total bilirubin (TBIL) significantly decreased in the study group, relative to control, but HBV DNAnegative, HbeAg-negative and HbsAg-negative cells were markedly higher in patients in the study group (p < 0.05). Moreover, there were higher CD4+ T and CD8+ T counts, and CD4+ T/CD8+ T ratio in study subjects than in control subjects (p < 0.05). Conclusion: The combination of tenofovir with interferon α1b effectively improves liver functions in patients with CHB, reduces viral load, and exerts anti-HBV effect by regulating the levels of peripheral blood T-lymphocytes.


  • Open Access

    Pulmonary nocardiosis in a patient with pemphigus foliaceus: case report and literature review

    by Ning Luo, Shifan Tan, Xiaocai Li, Si Liu, Shivank Singh, Mafeng Chen, Weiye Yang, Yanhong He, Chunna Chen, Min Liang

    Nocardiosis is an uncommon opportunistic infection seen in immunocompromised patients or those with a dysfunctional immune system. Nocardia asteroides infection in patients with Pemphigus foliaceus (PF) has never been reported. We report an interesting case of nocardiosis-characterized by pulmonary intra-cavitary infection, in a 54-year-old man with PF and diabetes mellitus. The man finally recovered from the infection. This is the first case reporting pulmonary nocardiosis in a patient with PF. We recommend that physicians be aware of nocardiosis in patients with pemphigus as a possible cause of underlying infectious disease to avoid misdiagnoses and mismanagement.


  • Open Access

    Image Restoration for Low-Dose CT via Transfer Learning and Residual Network

    by Anni Zhong, Bin Li, Ning Luo, Yuan Xu, Linghong Zhou, Xin Zhen

    Deep learning has recently been extensively investigated to remove artifacts in low-dose computed tomography (LDCT). However, the power of transfer learning for medical image denoising tasks has not been fully explored. In this work, we proposed a transfer learning residual convolutional neural network (TLR-CNN) to restore LDCT images at single and blind noise levels. A residual network was implemented to effectively estimate the difference between denoised image and its original map, and a noise-free image was obtained by subtracting the residual map from the LDCT image. The results were compared to competing baseline denoising methods in terms of quantitative metrics including the PSNR, RMSE, SSIM and FSIM. For the single noise level, the proposed method demonstrated better denoising performance than the other algorithms for both simulation data and clinical data. As for the blind denoising, the image qualities were improved for all noise levels for all the quantitative metrics, but such improvements were decreasing as the noise level decrease (higher mAs). Comparative experiments suggested that the proposed network could effectively suppress artifacts and preserve image details with faster converge rate and reduced computational time.


  • Open Access

    A Crosstalk between the Smad and JNK Signaling in the TGF-β-Induced Epithelial-Mesenchymal Transition in Rat Peritoneal Mesothelial Cells

    by Qinghua Liu, Yu Zhang, Haiping Mao, Wei Chen, Ning Luo, Qin Zhou, Wenfang Chen, Xueqing Yu

    Transforming growth factor β (TGF-β) induces the process of epithelial-mesenchymal transition (EMT) through the Smad and JNK signaling. However, it is unclear how these pathways interact in the TGF-β1-induced EMT in rat peritoneal mesothelial cells (RPMCs). Here, we show that inhibition of JNK activation by introducing the dominant-negative JNK1 gene attenuates the TGF-β1-down-regulated E-cadherin expression, and TGF-β1-up-regulated α-SMA, Collagen I, and PAI-1 expression, leading to the inhibition of EMT in primarily cultured RPMCs. Furthermore, TGF-β1 induces a bimodal JNK activation with peaks at 10 minutes and 12 hours post treatment in RPMCs. In addition, the inhibition of Smad3 activation by introducing a Smad3 mutant mitigates the TGF-β1-induced second wave, but not the first wave, of JNK1 activation in RPMCs. Moreover, the inhibition of JNK1 activation prevents the TGF-β1-induced Smad3 activation and nuclear translocation, and inhibition of the TGF-β1-induced second wave of JNK activation greatly reduced TGF-β1-induced EMT in RPMCs. These data indicate a crosstalk between the JNK1 and Samd3 pathways during the TGF-β1-induced EMT and fibrotic process in RPMCs. Therefore, our findings may provide new insights into understanding the regulation of the TGF-β1-related JNK and Smad signaling in the development of fibrosis.


  • Open Access

    Treatment of Established Peritoneal Fibrosis by Gene Transfer of Smad7 in a Rat Model of Peritoneal Dialysis

    by Yanyan Sun, Fengxin Zhu, Xueqing Yu, Jing Nie, Fengxian Huang, Xiaoyan Li, Ning Luo, Hui Yao Lan, Yongtao Wang

    Background/Aims: It has been shown that blockade of TGF-β1 signaling with Smad7 prevents experimental peritoneal fibrosis. The present study investigated whether Smad7 has a therapeutic effect on established peritoneal fibrosis associated with peritoneal dialysis (PD). Methods: A rat model of peritoneal fibrosis was induced by a daily intraperitoneal infusion of 4.25% Dianeal. After peritoneal fibrosis had been established on day 14, groups of 6 rats were treated intraperitoneally with gene transfer of Smad7 or control plasmids using an ultrasound-microbubble-mediated system for 2 weeks until day 28. In addition, a group of 6 diseased rats was euthanized on day 14 before treatment as the basal disease control. Results: Compared to the control-treatment animals on day 28, real-time PCR, Western blot, and confocal microscopy revealed that Smad7 gene transfer significantly attenuated the increased peritoneal fibrosis including the thickening of fibrotic peritoneum, accumulation of α-SMA and collagen I, and an improvement in peritoneal dysfunction (all p < 0.05). Importantly, Smad7 treatment also improved the severity of peritoneal fibrosis and functional impairment when compared to those on day 14 before treatment (all p < 0.05). Inhibition of the established peritoneal fibrosis by Smad7 was associated with an abrogation of TGF-β signaling and upregulation of TGF-β1 and PAI-1. Conclusions: Smad7 gene therapy is able to inhibit established peritoneal fibrosis in a rat model of PD. Results from this study suggest that Smad7 may be a therapeutic agent for the treatment of peritoneal fibrosis associated with PD.